PFIZER INC (PFE) vs Palantir Technologies Inc.(PLTR)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | PFE | PLTR |
|---|---|---|
| Sector | Health Care | Information Technology |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $62.58B | $4.48B |
| Revenue growth (YoY) | ▼ 1.6% | ▲ 56.2% |
| Net income | $7.81B | $1.63B |
| Gross margin | — | 82.4% |
| Diluted EPS | $1.36 | $0.63 |
| Insider net (6 mo) | +130.5K sh · 2 sells · 3 buys | −2.6M sh · 24 sells · 0 buys |
| Institutional owners | 44 | 47 |
| Institutional value held | $61.93B | $133.54B |
| Next earnings (est.) | Nov 3, 2026 | Nov 2, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
About Palantir Technologies Inc. (PLTR)
Palantir Technologies, founded in 2003, builds software platforms that enable organizations to integrate data, decisions, and operations at scale, originally serving the U.S. intelligence community before expanding into commercial markets.
Source: SEC EDGAR.